All In MedTech

FDA Clearance Tracker · P150012-S096

ImageReady MR Conditional Pacing System and INGEVITY Pace/Sense Lead

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 26, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 26, 2020

Approved

Time to decision

55 days

Received Jul 2, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150012-S096
Device name
ImageReady MR Conditional Pacing System and INGEVITY Pace/Sense Lead
Applicant location
St Paul, MN
Received
Jul 2, 2020
Decided
Aug 26, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P150012

Device type

Device class
Class III

Every decision under product code LWP

FDA's approval statement

As written in FDA's record.

Approval for labeling updates for the ImageReady MR Conditional Pacing System and INGEVITY Pace/Sense Lead based on the SAMURAI and INGEVITY clinical studies.

Source documents

Other decisions for Boston Scientific

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.